Eton Pharmaceuticals, Inc. Made Headway

Eton Pharmaceuticals, Inc. (ETON:NASDAQ) shot up at $3.59, representing a gain of 38.1%. On Fri, Aug 11, 2023, ETON:NASDAQ touched a New 2-Week High of $3.59. The stock appeared on our News Catalysts scanner on Thu, Aug 10, 2023 at 06:35 PM in the 'EARNINGS' category. From Fri, Jul 28, 2023, the stock recorded 50.00% Up Days and 36.36% Green Days
About Eton Pharmaceuticals, Inc. (ETON:NASDAQ)
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway, to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.
Top 10 Gainers:
- Amyris, Inc. (AMRS:NASDAQ), 107.74%
- IronNet Inc. (IRNT:NYSE), 94.55%
- Airspan Networks Holdings Inc. (MIMO:NYSEMKT), 83.47%
- Telesat Corporation (TSAT:NASDAQ), 53.49%
- Genius Group Limited (GNS:NYSEMKT), 46.01%
- Rigetti Computing Inc. (RGTI:NASDAQ), 39.02%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 38.96%
- Eton Pharmaceuticals, Inc. (ETON:NASDAQ), 38.08%
- Bitdeer Technologies Group (BTDR:NASDAQ), 35.41%
- ICZOOM Group Inc. (IZM:NASDAQ), 32.2%